Cyclacel announces sale of four patents to Celgene, dismissal of litigation

Jessica Perry//April 4, 2013

Cyclacel Pharmaceuticals Inc., in Berkeley Heights, announced today it will sell Celgene Corp., in Summit, four Cyclacel-owned patents in a $5.5 million deal.According to an announcement, as a result of the agreement, Cyclacel and Celgene have filed a joint stipulation and order for dismissal requesting the court enter an order dismissing a patent litigation dispute between the companies.